Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Woman Dies After Using Weight-Loss Drug In U.K.’s First Case
A 58-year-old nurse from Scotland has died after taking two doses of weight-loss drug tirzepatide, also known as Mounjaro or ...
Hosted on MSN3d
Novo Stock Has Been Slammed. How a New Weight-Loss Drug Could Boost Shares by 10%.
A mid-stage clinical trial of CagriSema showed that when combining the two drugs, patients’ body weight was reduced ...
MedPage Today on MSN3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
‘This Weight Loss Drug Helped My Mental Health Way More Than Any Other Medication’
The weight loss injection tirzepatide helped Melanie Ressa lose weight and overcome food noise, emotional eating, and mental ...
‘I Lost Over 50 Pounds From Zepbound—Here’s Why I Eventually Stopped Taking It’
When I lost weight on WW, I devoted all of my time to the program and I was successful. It was when life got hard that the ...
Weight Loss Injections: What You Need to Know, From Costs to Alternatives
Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...
Verywell Health on MSN6h
Zepbound Cuts the Risk of Progressing to Diabetes by 94%, Eli Lilly Data Shows
Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
Ozempic Could Prevent Diabetes. Should It Be Used for That?
New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...
Ozempic and Wegovy may be beneficial in fighting alcohol addiction: Study
The weight loss drugs Ozempic and Wegovy may be beneficial for people struggling with alcohol addiction, a study published ...
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data Shows
Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.
New Research Helps Kick The Fat For Good
GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...